Nicolas J. Schlienz

1.2k total citations
34 papers, 873 citations indexed

About

Nicolas J. Schlienz is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Applied Psychology. According to data from OpenAlex, Nicolas J. Schlienz has authored 34 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 10 papers in Experimental and Cognitive Psychology and 6 papers in Applied Psychology. Recurrent topics in Nicolas J. Schlienz's work include Cannabis and Cannabinoid Research (20 papers), Sleep and related disorders (7 papers) and Smoking Behavior and Cessation (6 papers). Nicolas J. Schlienz is often cited by papers focused on Cannabis and Cannabinoid Research (20 papers), Sleep and related disorders (7 papers) and Smoking Behavior and Cessation (6 papers). Nicolas J. Schlienz collaborates with scholars based in United States and United Kingdom. Nicolas J. Schlienz's co-authors include Ryan G. Vandrey, Edward J. Cone, Ronald Flegel, George E. Bigelow, John M. Mitchell, Dustin C. Lee, Tory R. Spindle, Eugene D Hayes, Larry W. Hawk and Rebecca J. Houston and has published in prestigious journals such as Cancer Research, Biological Psychiatry and SLEEP.

In The Last Decade

Nicolas J. Schlienz

33 papers receiving 850 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas J. Schlienz United States 17 594 192 170 157 129 34 873
Susan J. Boyd United States 15 400 0.7× 222 1.2× 343 2.0× 179 1.1× 135 1.0× 21 968
Hollis C. Karoly United States 19 389 0.7× 206 1.1× 149 0.9× 87 0.6× 130 1.0× 55 800
Pamela Sabioni Canada 13 663 1.1× 345 1.8× 153 0.9× 77 0.5× 79 0.6× 19 968
Mallory Loflin United States 15 846 1.4× 191 1.0× 109 0.6× 70 0.4× 109 0.8× 24 968
Susan M. Learned United States 15 255 0.4× 148 0.8× 259 1.5× 109 0.7× 105 0.8× 22 1.1k
Kelly A. Sagar United States 17 770 1.3× 208 1.1× 246 1.4× 39 0.2× 223 1.7× 33 1.0k
Dino Zagic Australia 7 633 1.1× 79 0.4× 126 0.7× 60 0.4× 94 0.7× 11 811
Gráinne Schäfer United Kingdom 10 959 1.6× 132 0.7× 372 2.2× 66 0.4× 254 2.0× 12 1.1k
Cecilia L. Bergeria United States 15 171 0.3× 182 0.9× 97 0.6× 233 1.5× 107 0.8× 58 729
Xavier Laqueille France 16 292 0.5× 140 0.7× 108 0.6× 61 0.4× 82 0.6× 77 835

Countries citing papers authored by Nicolas J. Schlienz

Since Specialization
Citations

This map shows the geographic impact of Nicolas J. Schlienz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas J. Schlienz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas J. Schlienz more than expected).

Fields of papers citing papers by Nicolas J. Schlienz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas J. Schlienz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas J. Schlienz. The network helps show where Nicolas J. Schlienz may publish in the future.

Co-authorship network of co-authors of Nicolas J. Schlienz

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas J. Schlienz. A scholar is included among the top collaborators of Nicolas J. Schlienz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas J. Schlienz. Nicolas J. Schlienz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schlienz, Nicolas J., Amy A. Case, Cheryl Rivard, et al.. (2024). Self-reported knowledge of tetrahydrocannabinol and cannabidiol concentration in cannabis products among cancer patients and survivors. Supportive Care in Cancer. 32(4). 210–210.
2.
Schlienz, Nicolas J., Nicholas J. Felicione, Dustin C. Lee, Richard J. O’Connor, & Danielle M. Smith. (2024). The Cannabis Gray Market: A Case for Cannabis Regulatory Science Research. Cannabis and Cannabinoid Research. 10(1). 6–10. 1 indexed citations
3.
Shisler, Shannon, Jin‐Kyung Lee, Nicolas J. Schlienz, et al.. (2024). Prenatal tobacco and tobacco-cannabis co-exposure: Relationship with attention and memory in middle childhood. Neurotoxicology and Teratology. 104. 107371–107371. 1 indexed citations
5.
Garcia‐Romeu, Albert, et al.. (2022). Online survey of medicinal cannabis users: Qualitative analysis of patient-level data. Frontiers in Pharmacology. 13. 965535–965535. 12 indexed citations
6.
Mahoney, Martin C., et al.. (2021). Transitioning to Remote Clinic Visits in a Smoking Cessation Trial During the COVID-19 Pandemic: Mixed Methods Evaluation. JMIR Formative Research. 5(4). e25541–e25541. 9 indexed citations
7.
Strickland, Justin C., et al.. (2021). Cross-sectional and longitudinal evaluation of cannabidiol (CBD) product use and health among people with epilepsy. Epilepsy & Behavior. 122. 108205–108205. 12 indexed citations
8.
Schlienz, Nicolas J., Tory R. Spindle, Edward J. Cone, et al.. (2020). Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis. Drug and Alcohol Dependence. 211. 107969–107969. 63 indexed citations
9.
Mahoney, Martin C., et al.. (2020). Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform. Journal of Substance Abuse Treatment. 117. 108100–108100. 7 indexed citations
10.
Schlienz, Nicolas J., et al.. (2020). A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health. Cannabis and Cannabinoid Research. 6(6). 548–558. 25 indexed citations
11.
Lee, Dustin C., Nicolas J. Schlienz, Erica N. Peters, et al.. (2018). Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder. Drug and Alcohol Dependence. 194. 500–517. 32 indexed citations
12.
Weigard, Alexander, Cynthia Huang‐Pollock, Andrew Heathcote, Larry W. Hawk, & Nicolas J. Schlienz. (2018). A cognitive model-based approach to testing mechanistic explanations for neuropsychological decrements during tobacco abstinence. Psychopharmacology. 235(11). 3115–3124. 4 indexed citations
13.
Vandrey, Ryan G., Alan J. Budney, Evan S. Herrmann, et al.. (2018). 166. Targeting Sleep Disturbance in the Treatment of Cannabis Use Disorders. Biological Psychiatry. 83(9). S67–S67. 1 indexed citations
14.
Houston, Rebecca J. & Nicolas J. Schlienz. (2017). Event-Related Potentials as Biomarkers of Behavior Change Mechanisms in Substance Use Disorder Treatment. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. 3(1). 30–40. 37 indexed citations
15.
Schlienz, Nicolas J., Alan J. Budney, Dustin C. Lee, & Ryan G. Vandrey. (2017). Cannabis Withdrawal: a Review of Neurobiological Mechanisms and Sex Differences. Current Addiction Reports. 4(2). 75–81. 63 indexed citations
16.
Gass, Julie C., Jennifer M. Wray, Lisa J. Germeroth, et al.. (2016). Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: A systematic review on varenicline. Drug and Alcohol Dependence. 169. 180–189. 18 indexed citations
17.
Schlienz, Nicolas J., Larry W. Hawk, Stephen T. Tiffany, Richard J. O’Connor, & Martin C. Mahoney. (2014). The impact of pre-cessation varenicline on behavioral economic indices of smoking reinforcement. Addictive Behaviors. 39(10). 1484–1490. 27 indexed citations
18.
Schlauch, Robert C., Cory A. Crane, Rebecca J. Houston, et al.. (2014). Psychometric Evaluation of the Substance Use Risk Profile Scale (SURPS) in an Inpatient Sample of Substance Users Using Cue-Reactivity Methodology. Journal of Psychopathology and Behavioral Assessment. 37(2). 231–246. 23 indexed citations
19.
Hawk, Larry W., et al.. (2012). The effects of varenicline on attention and inhibitory control among treatment-seeking smokers. Psychopharmacology. 223(2). 131–138. 30 indexed citations
20.
Godleski, Stephanie A., Jamie M. Ostrov, Rebecca J. Houston, & Nicolas J. Schlienz. (2010). Hostile attribution biases for relationally provocative situations and event-related potentials. International Journal of Psychophysiology. 76(1). 25–33. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026